Author(s):
Rahmayanti Fitriah, Nadiya Nurul Wafa, Guntur Kurniawan, Aminudin
Email(s):
rahmayanti.fitriah@unbl.ac.id
DOI:
10.52711/0974-360X.2026.00639 
Address:
Rahmayanti Fitriah*, Nadiya Nurul Wafa, Guntur Kurniawan, Aminudin
Faculty of Pharmacy, University of Borneo Lestari, Banjarbaru 70714, South Kalimantan, Indonesia.
*Corresponding Author
Published In:
Volume - 19,
Issue - 10,
Year - 2026
ABSTRACT:
Asthma is a chronic respiratory disease that requires long-term treatment with significant healthcare costs. Inhalation therapy is widely used due to its effectiveness in relieving symptoms with minimal systemic side effects. This study aimed to analyze the cost-effectiveness of inhalation therapies in inpatient asthma cases at RSD Idaman Banjarbaru South Kalimantan Indonesia. The research employed a non-experimental observational method with a descriptive-retrospective approach. Data were collected from 31 patient medical records, including inhalation therapy types, direct medical costs (drugs, medical personnel, and inpatient care), and therapy effectiveness measured by the average increase in oxygen saturation. Cost effectiveness was analyzed using the Average Cost Effectiveness Ratio (ACER) and Incremental Cost Effectiveness Ratio (ICER). The results showed that Berotec had the highest effectiveness (5%) and the lowest ACER value (Rp415,874 per 1% improvement), making it the most cost-effective therapy compared to Budesema, Pulmicort, Combivent, and Combivent + Pulmicort combination. Budesema showed the lowest effectiveness and cost-efficiency. ICER analysis confirmed these findings, with a negative ICER value in the Combivent + Pulmicort combination, indicating lower efficiency. These findings provide a valuable reference in selecting cost-effective inhalation therapy in healthcare services.
Cite this article:
Rahmayanti Fitriah, Nadiya Nurul Wafa, Guntur Kurniawan, Aminudin. Cost-Effectiveness Analysis of Inhalation Therapy for Inpatient Asthma patients at Idaman Regional Hospital Banjarbaru South Kalimantan Indonesia. Research Journal Pharmacy and Technology. 2026;19(10):4595-0. doi: 10.52711/0974-360X.2026.00639
Cite(Electronic):
Rahmayanti Fitriah, Nadiya Nurul Wafa, Guntur Kurniawan, Aminudin. Cost-Effectiveness Analysis of Inhalation Therapy for Inpatient Asthma patients at Idaman Regional Hospital Banjarbaru South Kalimantan Indonesia. Research Journal Pharmacy and Technology. 2026;19(10):4595-0. doi: 10.52711/0974-360X.2026.00639 Available on: https://rjptonline.org/AbstractView.aspx?PID=2026-19-10-15
REFERENCES:
1. Badan Kebijakan Pembangunan Kesehatan. Survey Kesehatan Indonesia (Ski) Tahun 2024.; 2023.
2. Punita R Maurya Ymjvjkadam. A Review On Bronchial Asthma. Research Journal Of Pharmacology And Pharmacodynamics. 2013; 5(4).
3. Naveen M, Santosh Y. Asthma: An Overview Introduction. Research J Pharm And Tech. 2011; 4(6): 883-890.
4. Andriyana KW, Ismunandar A, Maulana LH. Analisis Efektivitas Biaya Penggunaan Dry Powder Inhaler Pada Pasien Asma Di Klinik Paru RSUM Siti Aminah Bumiayu 2021; 2(2).
5. Witnalakorn Jittawat, Preutthipan Aroonwan, Oraluck Pattanaprateep, Wiparat Manuyakorn. Cost-Effectiveness Of Salbutamol Via Metered-Dose Inhaler With Spacers Versus Nebulizers In Children With Asthma Exacerbation In Middle Income Country. Asian Pac J Allergy Immunol. Published Online 2025. DOI:10.12932/Ap-160624-1872
6. Surya M S JPS. Knowledge And Practice Regarding Asthma Among Caregivers Of School Age Children With Asthma In A Tertiary Care Centre, Thiruvananthapuram. A And V Pub Journal Of Nursing And Medical Research. 2024; 3(3).
7. GINA. Global Initiative For Asthma Asthma Management And Prevention For Adults And Children Older Than 5 Years A Pocket Guide For Health Professionals Gina Executive Director.; 2020. www.ginasthma.org.
8. Lorensia A, Virlando Suryadinata R. Panduan Lengkap Penggunaan Macam-Macam Alat Inhaler Pada Gangguan Pernafasan. M-Brothers Indonesia; 2018. https://www.researchgate.net/publication/358543802
9. Waje MR, Gaikwad AS, Rathod KG, Shinde AA, Lad GS, Awati KP. Evolution And Advancements In Inhalation Therapy: A Comprehensive Review From Nebulizers To Dry Powder Inhalers. Res J Pharm Technol. 2025; 18(1): 436-444. DOI:10.52711/0974-360x.2025.00067
10. Azeez S, Kalathathoduvil S, Basheer S, Kankadyil Sp, Chandrashekar D. Use Of Inhaler Device In Patients With Asthma Or Chronic Obstructive Pulmonary Disease: Errors And Adherence Problems. Res J Pharm Technol. 2020; 13(9): 4130. DOI:10.5958/0974-360x.2020.00729.5
11. Riskesdas. Riskesdas 2018; 2019. www.litbang.depkes.go.id
12. CDC. Center For Disease Control And Prevention. 2020. Accessed April 23, 2025. https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm
13. Litanto A, Kartini. Kekambuhan Asma Pada Perempuan Dan Berbagai Faktor Yang Memengaruhinya: Sebuah Tinjauan. Jurnal Biomedika Dan Kesehatan. 2021; 4(2). DOI:10.18051/jbiomedkes.2021
14. Marsidi CF, Wiyono WI, Jayanti M. Hubungan Tingkat Kontrol Asma Dengan Kualitas Hidup Pasien Asma Bronkial Di Klinik Interna Rsud Kotamobagu. Jurnal Kesehatan Tambusai. 2023; 4.
15. Yuliani, Natalia S, Suangga F. Faktor-Faktor Yang Berhubungan Dengan Serangan Asma Pada Pasien Asma di Instalasi Rawat Jalan. Jurnal Review Pendidikan Dan Pengajaran. 2023; 6. Accessed May 5, 2025. http://journal.universitaspahlawan.ac.id/index.php/jrpp
16. Nivetha R, Arul B, Kothai R. Drug Induced Pulmonary Disease-A Mini Review. Res J Pharm Technol. 2019; 12(9): 4583-4588. DOI:10.5958/0974-360x.2019.00788.1
17. Mardiati. Kelainan Sistem Respiratorik Akibat Refluks Gastroesofagus. Jurnal Kesehatan Almuslim. 2020; (11).
18. Manese M, Bidjuni H, Rompas S. Faktor Resiko Yang Berhubungan Dengan Riwayat Serangan Pada Penderita Asma Di Kabupaten Minahasa Selatan. Jurnal Keperawatan. 2021; 9(2): 33-39.
19. Surdesh D. Kamble Lmpodvkr. In Vitro And In Vivo Evalution Of Anti-Asthmatic Activity Of Leaves Of Sida Veronicafolia (Lam). Research Journal Of Pharmacology And Pharmacodynamics. 2024; 16(4).
20. Azzahra NP, Yohanes DC, Sumiwi SA. Tinjauan Pustaka : Efek Jangka Panjang Penggunaan Kortikosteroid Inhalasi Pada Pasien Asma. Farmaka. 2023; 21(2).
21. Dave PH, Preetha. Pathogenesis And Novel Drug For Treatment Of Asthma – A Review. Res J Pharm Technol. 2016; 9(9): 1519-1523. Doi:10.5958/0974-360x.2016.00297.3
22. Emeryk A, Emeryk-Maksymiuk J. Short-Acting Inhaled B2-Agonists: Why, Whom, What, How? Adv Respir Med. 2020; 88(5): 443-449. Doi:10.5603/arm.a2020.0132
23. Lumbantobing VBM. Efektivitas Terapi Nebulizer Dengan Ipratropium Dan Fenoterol Terhadap Saturasi Oksigen. Jurnal Keperawatan Bsi. 2018; 5.
24. Lalsare SS. Comparative Evaluation Of Nebulizer Devices Present In Market And Factors Influencing Nebulizer Performance. Res J Pharm Technol. 2024; 17(11): 5605-5615. DOI:10.52711/0974-360x.2024.00855
25. Lorensia A, Bahari Fk. Analisis Efektifitas Biaya Antara Kombinasi Salbutamol-Ipratropium Dengan Salbutamol Pada Serangan Asma. Jurnal Insan Farmasi Indonesia. 2020; 3(1): 38-49. DOI:10.36387/jifi.v3i1.470
26. Akbar MA, Fitriah R, Akbar DO. Analisis Efektivitas Biaya Terapi Tunggal Dan Kombinasi Antihipertensi Pada Pasien Stroke di RSD Idaman Banjarbaru. 2025: 1(1).
27. Fitriah R, Wafa NN, Kurniawan G, Aminudin. Menakar Efektivitas Dan Efisiensi Terapi Inhalasi Astma Dalam Perspektif Farmakoekonomi Di Rumah Sakit. 2025. Dewa Publishing.